Business Context and Reporting Period
This Form 8-K is a current report filed by NorthView Acquisition Corp. (NVAC) on March 18, 2025. The filing addresses the adjournment of a Special Meeting of Shareholders originally scheduled for March 18, 2025, to March 21, 2025. The meeting concerns a proposal to extend the deadline for consummating an initial business combination from March 22, 2025, to July 22, 2025.
Key Financial Metrics
- Trust Account Per Share Value: Approximately $12.20 (prior to the new extension contribution).
- Public Shares Outstanding (Non-Redeemed): 44,561 shares as of March 14, 2025.
- Revised Sponsor Contribution: A fixed amount of $30,000 for the entire extension period (March 22, 2025, to June 22, 2025).
- Original Contribution Plan: Previously set at the lesser of $10,000 or $0.04 per outstanding public share per month.
- Interest Withdrawn for Taxes: Approximately $23,400 withdrawn from the trust account after the record date.
- Waived Dissolution Expenses: Up to $100,000 of interest previously available for dissolution expenses is now waived and retained in the trust.
Material Changes vs. Prior Period
- Meeting Adjournment: The Special Meeting was rescheduled to allow shareholders who previously tendered shares for redemption to reverse their decisions ("Redemption Reversals") in light of the revised financial terms.
- Contribution Structure Change: The Sponsor revised its contribution from a variable monthly amount ($0.04/share) to a lump sum of $30,000 for the extension period.
- Trust Account Restrictions: The Company waived its right to withdraw up to $100,000 for dissolution expenses and all future interest for tax expenses, increasing the potential liquidation value for shareholders if no business combination occurs.
Outlook, Risks, and Management Commentary
- Extension Proposal: Shareholders must approve the extension to July 22, 2025, to allow time to complete a business combination.
- Redemption Reversals: Shareholders who tendered shares for redemption may withdraw their tender until the adjourned meeting on March 21, 2025, by contacting the transfer agent.
- Forward-Looking Risks: The filing highlights risks regarding shareholder approval of the extension, the inability to complete a business combination within the new timeframe, and general market uncertainties.
- Proxy Solicitation: The Company will continue to solicit proxies prior to the adjourned meeting.
Investor Verification Checklist
- Verify the current per-share redemption price of $12.20 and confirm if the $30,000 contribution has been deposited.
- Confirm the deadline and procedure for reversing redemption tenders before the March 21, 2025, meeting.
- Review the revised Annex A to the Proxy Statement (Exhibit 99.1) for updated terms.
- Assess the impact of the $100,000 dissolution expense waiver on potential liquidation proceeds.
- Monitor the vote count for the Extension Proposal at the adjourned Special Meeting.